Australia markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
51.72-0.06 (-0.12%)
At close: 04:03PM EST
51.84 +0.12 (+0.23%)
After hours: 06:48PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 290.66B
Enterprise value 290.21B
Trailing P/E 9.92
Forward P/E 10.42
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.98
Price/book (mrq)3.14
Enterprise value/revenue 2.91
Enterprise value/EBITDA 7.36

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3-1.89%
S&P500 52-week change 3-15.89%
52-week high 361.71
52-week low 341.45
50-day moving average 346.59
200-day moving average 349.13

Share statistics

Avg vol (3-month) 320.35M
Avg vol (10-day) 320.25M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.05%
% held by institutions 170.49%
Shares short (14 Nov 2022) 470.04M
Short ratio (14 Nov 2022) 43.04
Short % of float (14 Nov 2022) 41.25%
Short % of shares outstanding (14 Nov 2022) 41.25%
Shares short (prior month 13 Oct 2022) 462.51M

Dividends & splits

Forward annual dividend rate 41.6
Forward annual dividend yield 43.09%
Trailing annual dividend rate 31.59
Trailing annual dividend yield 33.07%
5-year average dividend yield 43.59
Payout ratio 430.46%
Dividend date 304 Dec 2022
Ex-dividend date 402 Nov 2022
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)01 Oct 2022


Profit margin 29.81%
Operating margin (ttm)39.96%

Management effectiveness

Return on assets (ttm)13.32%
Return on equity (ttm)35.51%

Income statement

Revenue (ttm)99.88B
Revenue per share (ttm)17.81
Quarterly revenue growth (yoy)-5.80%
Gross profit (ttm)50.63B
Net income avi to common (ttm)29.95B
Diluted EPS (ttm)5.22
Quarterly earnings growth (yoy)5.70%

Balance sheet

Total cash (mrq)36.13B
Total cash per share (mrq)6.44
Total debt (mrq)37B
Total debt/equity (mrq)39.83
Current ratio (mrq)1.59
Book value per share (mrq)16.51

Cash flow statement

Operating cash flow (ttm)26.6B
Levered free cash flow (ttm)22.83B